The 2010 ACR-EULAR classification criteria for rheumatoid arthritis. Aletaha D et al. Arthritis Rheum 2010 Sep;69(9):1580-8. doi:10.1002/art.27584

more Information

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G et al. Arthritis Rheum 2007; 56(8):2503-11. – doi:10.1002/art.22817

more Information

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Coenen D, Verschueren P, Westhovens R, Bossuyt X. Clin Chem 2007; 53(3):498- 504. – doi:10.1373/clinchem.2006.078063

more Information

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Dejaco C, Klotz W, Larcher H, et al. Arthritis Res Ther 2006; 8(4):R119.

more Information

The Serological Diagnosis of Rheumatoid Arthritis – Antibodies to citrullinated Antigens [Serologische Diagnostik der rheumatoiden Arthritis: Antikörper gegen citrullinierte Antigene]. Egerer K, Feist E, Burmester G. Dtsch Arztebl Int 2009; 106(10):159-63 – doi:10.3238/arztebl.2009.0159

more Information

Anti-Citrullinated Protein-Peptide Antibodies in Rheumatoid Arthritis [Anticitrullinierte Protein/Peptid-Antikörper bei rheumatoider Arthritis]. Gross WL, Moosig F, Lamprecht P. Dtsch Arztebl Int 2009; 106(10):157–8 – doi:10.3238/arztebl.2009.0157

more Information

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. Harre U, Georgess D, Bang H et al. J Clin Invest. 2012 May 1;122(5):1791-802. – doi:10.1172/JCI60975.

more Information

Antibodies Against Mutated Citrullinated Vimentin Are a Better Predictor of Disease Activity at 24 Months in Early Rheumatoid Arthritis Than Antibodies Against Cyclic Citrullinated Peptides. Innala L, Kokkonen H, Eriksson C, et al. J Rheumatol 2008.

more Information

Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Koivula MK, Heliövaara M, Rissanen H, Palosuo T, Knekt P, Immonen H, Risteli J. Ann Rheum Dis 2012 Mar 14. [Epub ahead of print]

more Information

Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Mathsson L, Mullazehi M, Wick MC, et al. Arthritis Rheum 2007; 58(1):36-45. – doi:10.1002/art.23188

more Information

Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, Grootenboer-Mignot S, Dieudé P, Dougados M, Cantagrel A, Meyer O, Serre G, Chollet- Martin S. Ann Rheum Dis. 2012 May 12. [Epub ahead of print]

more Information

Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis. Poulsom H, Charles PJ. Clin Rev Allergy Immunol 2008; 34(1):4-10. – doi:10.1007/s12016-007-8016-3

more Information

Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis. Qin X, Deng Y, Xu J, et al Rheumatol Int. 2010 Mar 10.

more Information

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Roland PN, Mignot SG, Bruns A, et al. Arthritis Res Ther. 2008 Dec 10;10(6):R142. – doi:10.1186/ar2570

more Information

Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets? Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, Vegvari A et al. Clin Rev Allergy Immunol 2008; 34(1):26-31. – doi:10.1007/s12016-007-8022-5

more Information

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a ten-year prospective study. Syversen SW, Goll GL, van der Heijde D, et al. Ann Rheum Dis. 2009 Jul 30. – doi:10.1136/ard.2009.113092

more Information

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Van Steendam K, Tilleman K, Dieter Deforce D. Rheumatology (Oxf ord). 2011 May; 50(5): 830–837. – doi:10.1093/rheumatology/keq419

more Information

Antibody against mutated citrullinated vimentin: a sensitive marker in the diagnosis of rheumatoid arthritis. Wagner E, Skoumal P, Bayer PM, Klaushofer K. Rheumatol Int. 2009 Jan 28 – doi:10.1007/s00296-009-0854-2

more Information

Association of Anti-Modified Citrullinated Vimentin with Subclinical Atherosclerosis in Early Rheumatoid Arthritis Compared with Anti-Cyclic Citrullinated Peptide. El-Barbary AM, Kassem EM, El-Sergany MA, et al. J Rheumatol, 2011, 38(5):828-34 – doi:10.3899/jrheum.101143

more Information

target="_blank">more Information

Cookies erleichtern die Bereitstellung unserer Dienste. Mit der Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies verwenden.
Weitere Informationen Ok